Emergency contraception


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review presents modern data on the currently used methods of emergency contraception (EC) (non-pharmacological and hormonal), the features of their use and effectiveness. Levonorgestrel-containing tablets (Escapel) is the most popular EC product, it provides a contraceptive effect with a probability of pregnancy of only 1.1%. The safety of a single dose of 1.5 mg of levonorgestrel is confirmed by the results of numerous studies. In the Emergency Contraception Consortium, this regimen is recommended as a first-choice method.

Full Text

Restricted Access

About the authors

Tamara N. Bebneva

Peoples' Friendship University of Russia

Email: bebn@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Obstetrics, Gynecology and Reproductive Medicine, Faculty of Continuous Education of Medical Workers, Medical Institute

References

  1. Петров Ю.А., Байкулова Т.Ю. Современные пред -ставления о проблеме искусственного прерывания беременности. Международный журнал прикладныхи фундаментальгных исследований. 2016;8:727-31. [Petrov Yu.A., Baykulova T.Yu. Modern ideas about the problem of artificial termination of pregnancy Mezhdunarodnyi zhurnal prikladnykh i fundamental'nykh issledovaniy. 2016;8:727-31. (in Russ.)].
  2. Wu S., Godfrey E.M., Wojdyla D., et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG. 2010;117(10):1205-10.
  3. Turok D.K., Godfrey E.M., Wojdyla D., et al. Copper T-380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Hum. Reprod. 2013;28(10):2672-76. doi: 10.1093/humrep/ det330.
  4. Goldstuck N.D., Cheung T.S. The efficacy of intrauterine devices for emergency contraception and beyond: a systematic review update. int J Womens Health. 2019;11:471-79. Doi:10.2147/ JWH.S213815.
  5. Turok D.K., Sanders J.N., Thompson i.S., et al. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel iUD: a prospective cohort study. Contraception. 2016;93(6):526 32. Doi:W.W16/j.contraception.2016.01.009
  6. Yuzpe A.A, Thurlow H.J., Ramzy i., Leyshon J.i. Post coital contraception - A pilot study. J Reprod Med. 1974;13(2):53-8.
  7. Curtis K.M., Jatlaoui T.C., Tepper N.K., et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(4):1-66. doi: 10.15585/mmwr. rr6504a1.
  8. American College of Obstetricians and Gynecologists. Practice Bulletin No. 152: emergency contraception. Obstet Gynecol. 2015;126(3):e1-11. doi: 10.1097/A0G.0000000000001047.
  9. Martinez G., Copen C.E., Abma J.C. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth. Vital Health Stat. 2011; (31):1-35.
  10. Piaggio G., Heng Z., von Hertzen H., et al. Combined estimates of effectiveness of mifepristone 10 mg in emergency contraception. Contraception. 2003;68(6):439-46.
  11. Pharma H.R.A. FDA advisory committee unanimously recommends approval of HRA pharma's ulipristal acetate for emergency contraception. 2010. Available at: https:// ec.princeton.edu. Accessed January 7, 2019.
  12. Medical eligibility criteria for contraceptive use. 5th ed. Switzerland: WHO, 2015. 267 р
  13. Emergency contraceptive pills. Medical and Service Delivery Guidance. international Consortium for Emergency Contraception, international Federation of Gynecologists and Obstetricians. 4th ed. 2018. 24 р. Available at: https://www.cecinfo.org
  14. Casteel C., Martin S.L., Smith J.B., et al. National study of physical and sexual assault among women with disabilities. inj Prev. 2008;14(2):87-90.
  15. Glasier A., Cameron S.T., Fine P.M., Logan S.J., Casale W., Van Horn J., et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized noninferiority trial and meta-analysis. Lancet. 2010;375:555-62. doi: 10.1016/S0140-6736(10)60101-8.
  16. WHO. Model list of essential medicines. 19th ed. Geneva: WHO, 2015. Available at: http:// mednet3.who.int/EMLib.
  17. Cleland K., Raymond E.G., Westley E., Trussell J. Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol. 2014;57(4):741-50. Doi:10.1097/ GRF.0000000000000056.
  18. Дикке ГБ. Пять шагов к успешной контрацепции: Руководство для врачей. М., 2017. 430 с. [Dikke G.B. Five Steps to Successful Contraception: A Guide for Physicians. M., 2017. 430 p. (In Ruuss.)].
  19. Бебнева Т.Н. Применение Эскапела - средства для экстренной контрацепции у женщин в различные возрастные периоды. Основы консультирования. РМЖ. 2007;2:134. [Bebneva T.N. Application of Escapel-means for emergency contraception in women in different age periods. Basics of consulting. Russkiy meditsinskiy zhurnal. 2007;2:134. (in Ruuss.)].

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies